Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients With Bladder Cancer

This cross-sectional analysis compares downstaging, responses, and survival outcomes in patients with muscle-invasive bladder cancer treated with cystectomy who underwent neoadjuvant chemotherapy with gemcitabine with cisplatin, gemcitabine with carboplatin, or dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin.

https://ift.tt/2C1lXLm